Back
EAPC Premium Access

Potential use of PCSK9 inhibitors in secondary prevention for patients with treated acute coronary syndrome. A study from a large UK university teaching hospital

Session: Poster Session I - Thursday 08:30 - 18:00 - Diabetes/ Lipids/Obesity/Nutrition_Part 2
Topic: Lipids
Speaker: Doctor A. Elamin (Liverpool, GB)
Event: EuroPrevent 2017

Congress Presentation

About the speaker

Doctor Ahmed Farouk Mohamed Elamin

Liverpool Heart and Chest Hospital, Liverpool (United Kingdom of Great Britain & Northern Ireland)
0 follower

8 more presentations in this session

Diabetes/ Lipids/Obesity/Nutrition_Part 2 - Poster discussant: .

Access
Thumbnail

Familial heterozygous dyslipidemia evaluation in lipid treated populations : FHELP

Speaker: Doctor J. Daigle (Halifax, CA)

Access
Slides
Thumbnail

Age-related differences in the lipid profile in patients admitted to a cardiac rehabilitation program

Speaker: Doctor A. Chauca Tapia (Girona, ES)

Access
Abstract
Thumbnail

Statin-treated patients: are the lipid goals reached?

Speaker: Doctor K. Mzoughi (Tunis, TN)

Access
Abstract
Thumbnail

Lipid profile comparisons in women with acute myocardial infarction of different age

Speaker: Associate Professor D. Platonov (Tver, RU)

Access
Thumbnail

Access the full session

Poster Session I - Thursday 08:30 - 18:00 - Diabetes/ Lipids/Obesity/Nutrition_Part 2

Speakers: Doctor A. Elamin, Doctor J. Daigle, Doctor A. Chauca Tapia, Doctor K. Mzoughi, Associate Professor D. Platonov
Access
Thumbnail

About the event

Image

EuroPrevent 2017

6 April - 8 April 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb